Metraipolis › archive › dc_fcba5a579a13

Immune checkpoint TIM-3 in tumor immunotherapy — Europe PMC PMID:41437770

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41437770
DOI
10.3724/abbs.2025235
License (as archived)
solo-consultazione
Archived
2026-11-07T10:49:07.141Z
SHA-256 of the archived text
39ed33625b1ebcc2cc490c2bae5aff7bf44be7179d1e26a26de34e51e04176fe
Stable URL of this page
https://metraipolis.com/documento/dc_fcba5a579a13

How to cite

Immune checkpoint TIM-3 in tumor immunotherapy — Europe PMC PMID:41437770 — Europe PMC (en), https://europepmc.org/article/MED/41437770 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fcba5a579a13 (Metraipolis archive dc_fcba5a579a13, sha256 39ed33625b1ebcc2cc490c2bae5aff7bf44be7179d1e26a26de34e51e04176fe)
BibTeX
@misc{dcfcba5a579a13,
  title = {Immune checkpoint TIM-3 in tumor immunotherapy — Europe PMC PMID:41437770},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41437770},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fcba5a579a13; sha256 39ed33625b1ebcc2cc490c2bae5aff7bf44be7179d1e26a26de34e51e04176fe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41437770. Agents can read the archived copy with the MCP tool read_document.